CATALOGO DEI PRODOTTI DELLA RICERCA

Ciccarese, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.956
EU - Europa 2.755
AS - Asia 1.917
SA - Sud America 254
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 74
OC - Oceania 1
Totale 8.047
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.831
RU - Federazione Russa 1.054
SG - Singapore 695
GB - Regno Unito 658
CN - Cina 617
IT - Italia 281
BR - Brasile 184
SE - Svezia 182
VN - Vietnam 176
IE - Irlanda 147
HK - Hong Kong 144
DE - Germania 133
FR - Francia 113
KR - Corea 59
CA - Canada 54
FI - Finlandia 53
BD - Bangladesh 41
IN - India 37
AR - Argentina 31
MX - Messico 30
PL - Polonia 26
NL - Olanda 25
JP - Giappone 24
TR - Turchia 23
ID - Indonesia 20
NG - Nigeria 20
ZA - Sudafrica 15
ES - Italia 13
UA - Ucraina 13
EC - Ecuador 12
IQ - Iraq 12
MA - Marocco 11
BE - Belgio 9
VE - Venezuela 8
AT - Austria 7
LT - Lituania 7
PH - Filippine 7
PK - Pakistan 7
AZ - Azerbaigian 6
CO - Colombia 6
GT - Guatemala 6
MY - Malesia 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
HN - Honduras 5
JM - Giamaica 5
KE - Kenya 5
PY - Paraguay 5
AL - Albania 4
CH - Svizzera 4
CL - Cile 4
CR - Costa Rica 4
EU - Europa 4
SA - Arabia Saudita 4
SV - El Salvador 4
CW - ???statistics.table.value.countryCode.CW??? 3
EG - Egitto 3
GP - Guadalupe 3
GR - Grecia 3
JO - Giordania 3
LK - Sri Lanka 3
PR - Porto Rico 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
BG - Bulgaria 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
NI - Nicaragua 2
NP - Nepal 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HT - Haiti 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
Totale 7.951
Salva come PNG Salva come JPEG
Città #
Southend 609
Ashburn 394
Singapore 358
Moscow 356
San Jose 314
Chandler 300
Dallas 190
Beijing 147
Dublin 147
Hong Kong 143
Woodbridge 105
The Dalles 98
Council Bluffs 90
Verona 75
Ann Arbor 74
Los Angeles 71
New York 62
Houston 61
Ho Chi Minh City 48
Jacksonville 46
Lawrence 46
Princeton 46
Nanjing 42
Wilmington 39
Santa Clara 37
Hanoi 32
Jinan 31
São Paulo 31
Shenyang 26
Montreal 25
Abuja 20
Buffalo 20
Redondo Beach 20
Tokyo 20
Columbus 19
Denver 19
Hebei 19
Chicago 18
Brooklyn 17
Munich 17
Helsinki 16
Tianjin 16
Changsha 15
Milan 14
Redwood City 14
Dong Ket 13
Frankfurt am Main 13
Guangzhou 13
Haikou 13
Sindelfingen 13
Zhengzhou 13
Stockholm 12
Warsaw 12
Johannesburg 11
London 11
Mexico City 11
Rome 11
Seoul 11
Bologna 10
Jakarta 10
Orem 10
Taizhou 10
Amsterdam 9
Boston 9
Da Nang 9
Jiaxing 9
Las Vegas 9
Brussels 8
Dearborn 8
Ningbo 8
Norwalk 8
Phoenix 8
Biên Hòa 7
Chennai 7
Dhaka 7
Fuzhou 7
Kent 7
Nanchang 7
Seattle 7
Vienna 7
Ankara 6
Baku 6
Campinas 6
Guatemala City 6
Hangzhou 6
Lanzhou 6
San Francisco 6
Taiyuan 6
Tashkent 6
Turku 6
Haiphong 5
Istanbul 5
Krakow 5
New Delhi 5
Paris 5
Atlanta 4
Bussolengo 4
Casablanca 4
Catania 4
Catanzaro 4
Totale 4.750
Salva come PNG Salva come JPEG
Nome #
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 264
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 244
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 227
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 227
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 220
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 216
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 214
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 203
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 202
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 200
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 200
AR-V7 and prostate cancer: The watershed for treatment selection? 198
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 198
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 197
The development of PARP as a successful target for cancer therapy 196
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 196
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 189
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 187
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 185
2015 and human cancer: back to overall survival 178
Metabolic phenotype of bladder cancer 174
Metabolic alterations in renal cell carcinoma 173
The route to personalized medicine in bladder cancer: where do we stand? 172
Inside the 2015 ASCO Genitourinary Cancers Symposium 166
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice 162
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 161
Bladder cancer: molecular determinants of personalized therapy 161
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 160
Metabolic Alterations in Renal and Prostate Cancer 159
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer 159
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies 155
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer 155
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer 153
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 150
Acquired hemophagocytic syndrome: comment to the case report 145
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 139
Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR? 139
Emerging Immunotargets in Bladder Cancer 138
Kidney cancer and 2014: is innovation really over? 137
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis 127
Role of STAT3 pathway in genitourinary tumors 122
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 118
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 111
Tp53 and its potential therapeutic role as a target in bladder cancer 107
PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer 102
The prospect of precision therapy for renal cell carcinoma 100
Present and future of personalized medicine in adult genitourinary tumors 78
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 70
The prognostic value of pain in castration-sensitive prostate cancer 13
Totale 8.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.834
article - articoli 27.834
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.668
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022167 0 0 0 0 23 8 3 21 10 8 11 83
2022/2023827 54 96 72 136 59 221 2 62 93 11 17 4
2023/2024357 13 34 25 32 75 36 10 39 5 18 60 10
2024/20251.019 48 54 51 234 27 37 23 20 199 47 87 192
2025/20263.512 220 162 212 707 898 216 266 163 316 216 52 84
2026/2027474 24 68 116 246 20 0 0 0 0 0 0 0
Totale 8.047